Nervous system Very common (10% or more): Dysesthesia (up to 22%), headache (up to 17%) Common (1% to 10%): Dizziness, dysgeusia Uncommon (0.1% to 1%): Syncope Postmarketing reports : Headache, dizziness, dysgeusia, dysesthesia Dysesthesia included allodynia, burning sensation, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization
By addressing them directly, Semaglutide can finally do its job more effectively
There was also a significant 26% relative risk reduction in the primary composite outcome (the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in the semaglutide group compared to the placebo group
But if side effects like fatigue, nausea, or a muted mood kick in, or if food restriction starts taking a toll, that same spark might feel harder to access